z-logo
open-access-imgOpen Access
A novel therapeutic strategy for Alzheimer’s disease: utility of peptides targeting phospholipase A2 and able to cross the blood-brain barrier through the LDL receptor
Author(s) -
Séverine André,
Jean Atakana,
Marine Lecomte,
Robert N. Müller,
Luce Vander Elst,
Sophie Laurent,
Carmen Burtéa
Publication year - 2018
Publication title -
frontiers in neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.499
H-Index - 102
eISSN - 1662-4548
pISSN - 1662-453X
DOI - 10.3389/conf.fnins.2018.95.00064
Subject(s) - blood–brain barrier , phospholipase a2 , pharmacology , alzheimer's disease , ldl receptor , medicine , disease , neuroscience , computational biology , chemistry , biology , biochemistry , enzyme , central nervous system , cholesterol , lipoprotein

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here